Skip to main content

INDIA- A need to develop our own In house safety database solution

In the recent times we have seen a growing prevalence of diseases and chronic disorders, in order to eradicate life threatening diseases and chronic conditions, we have made one leap forward towards developing an effective pharmacovigilance system, with the sole aim to provide robust patient safety, through monitoring adverse drug reactions, signal detection and risk management plan.

Collection, detection, assessment and monitoring of adverse event through icsr pharmacovigilance  requires specialized IT framework with the capabilities of Intelligent Automation for computing frequency of adverse events using complex algorithms and statistical disproportions, which will help us then to understand the benefit-risk profile of the drug, paving way for an effective risk management plan.

With PvPI facilitating drug safety activities in India, In the current scenario there is an strong need for collaboration of IT segment with PvPI to build an in house safety solution which will encompass all the capabilities for carrying out end to end pharmacovigilance process and at the same time it should be made available for patient/ healthcare professionals as a cloud based services or android/IOS service for direct reporting of adverse events.


This service could be linked to Aadhar card, where in which a patient or HCP when reporting an adverse event, by simply entering the telephone number or UID will get an OTP on their smartphone and then after providing the OTP, the end user would have complete access to his/her own database which would include the number of previous adverse event reports submitted, current status of reports, this would also enable auto filling of contact details in adverse event monitoring using machine learning. 

By 
Joseph Mathew 
Sr. Manager- Think i

We at Think i would like to announce our partnership with AB Cube Solutions, France to bring state-of-the-art safety database solutions.

AB Cube, France provides cloud based software solutions for vigilance which are not only cost effective and user friendly but also fully validated for quick, easy  import, entry and electronic submissions of adverse event in Human Drugs, Medical Devices, Cosmetics, Nutraceuticals and veterinary products.

For more details, please visit our website  www.thinki.in or email us at medical@thinki.in 
You may contact also us at +91 9560102587 or +91 9810068241
Labels:

Comments

Post a Comment

Popular posts from this blog

Chat Bot- the first artificial intelligence bot in Pharmacovigilance

Merck Sharp & Dohme (MSD) Corp., a subsidiary of Merck & Co., Inc has developed an Artificial Intelligence (AI) chat bot. The MSD Salute chat bot is designed to aid physicians in providing product information and pathology.  The Physicians who are registered with MSD would use the Chat bot using facebook messenger.  Chat bot is derived from the social media and uses machine learning and implements feedback to develop interactions.  Currently MSD is monitoring and not filtering the communication between Chat bot and users, as they want to analyse the open ended exchanges between the AI and the users. Chat bot currently in the testing phase, is said augment patient safety through proactive pharmacovigilance .  We at Think I are also driven to produce Pharmacovigilance safety database solutions using cloud based technology which are not only cost effective and user friendly but also fully validated for quick, easy import, entry and electronic submissions of adve
11 comments
Read more

Pharmacovigilance system- Industry perspective, Market size and Operations

Monitoring adverse drug reaction is an essential component in patient safety. In the last decade we have seen how technology has influenced the entire healthcare system, leading to patient awareness, thus making the pharmaceutical companies and regulatory authorities to invest more time and resource in monitoring adverse events. Pharmacovigilance as per WHO is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem Pharmacovigilance is the study of adverse events taking into account all the plausible relationship or untoward medical occurrence which the patent experienced after taking the drug and then using standard set of coordinated activities which involves first collecting adverse event reports either via telephone, email, social network, lay press , media. After adverse event reports are filed we then process and assess these reports in database to determine if indee
3 comments
Read more

Artificial Intelligence Seeing through the lens of Pharmacovigilance

Pharmacovigilance as we know is a science with a set of pre defined functions to collect, analyse, monitor adverse event reports in understanding the safety profile of drug. The set pre defined functions would include case processing through data entry of adverse event forms into safety database, medical review, aggregate reporting, signal detection, risk evaluation and mitigation strategies. With patients awareness and regulatory compliance we may have seen a surge of adverse event data over last few years , resulting in the urgent need for the application of automation. Pharmacovigilance is the only discipline where in which timelines and quality data are evaluated on a benchmark of 100 % and a compromise in these two parameters are considered to be a zero tolerance. Automation of above pre defined function is possible through machine learning, which is an integral components of Artificial Intelligence. What is Artificial Intelligence ?        Artificial intellig
2 comments
Read more